Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Dec;30(12):2684-2686.
doi: 10.3201/eid3012.241470. Epub 2024 Oct 7.

Replication-Competent Oropouche Virus in Semen of Traveler Returning to Italy from Cuba, 2024

Case Reports

Replication-Competent Oropouche Virus in Semen of Traveler Returning to Italy from Cuba, 2024

Concetta Castilletti et al. Emerg Infect Dis. 2024 Dec.

Abstract

A febrile man in Italy who had traveled to Cuba in July 2024 was diagnosed with Oropouche fever. Reverse transcription PCR detected prolonged shedding of Oropouche virus RNA in whole blood, serum, urine, and semen. Sixteen days after symptom onset, replication-competent virus was detected in semen, suggesting risk for sexual transmission.

Keywords: Cuba; Italy; Oropouche virus; PCR; arboviruses; bunyaviridae infections; isolation and purification; reproductive health; semen; vector-borne infections; viruses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical events and laboratory findings associated with OROV infection in a 42-year-old man from Italy who visited Cuba during July 19–29, 2024. Shown is clinical timeline of patient’s OROV infection, with key days indicating the onset of symptoms and the results of both endpoint and real-time RT-PCR tests of whole blood, serum, urine, and semen samples. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CHIKV, chikungunya virus; Ct, cycle threshold; DENV, dengue virus; eGFR, estimated glomerular filtration rate; NT, not tested; neg, negative; OROV, Oropouche virus; pos, positive; RT-PCR, reverse transcription PCR; ZIKV, Zika virus.
Figure 2
Figure 2
Cytopathic effect associated with Oropouche virus infection in a 42-year-old man from Italy who visited Cuba during July 19–29, 2024, observed by using light microscopy on Vero E6 cells monolayer after 5 days of incubation. A) Semen sample from patient (Appendix). B) Semen sample from uninfected control. Original magnification ×10.

References

    1. Wesselmann KM, Postigo-Hidalgo I, Pezzi L, de Oliveira-Filho EF, Fischer C, de Lamballerie X, et al. Emergence of Oropouche fever in Latin America: a narrative review. Lancet Infect Dis. 2024;24:e439–52. 10.1016/S1473-3099(23)00740-5 - DOI - PubMed
    1. Pan American Health Organization/World Health Organization. Epidemiological update: Oropouche in the Americas Region, 6 September 2024. [cited 2024 Oct 3]. https://www.paho.org/en/documents/epidemiological-update-oropouche-ameri...
    1. Morrison A, White JL, Hughes HR, Guagliardo SAJ, Velez JO, Fitzpatrick KA, et al. Oropouche virus disease among U.S. travelers—United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73:769–73. 10.15585/mmwr.mm7335e1 - DOI - PMC - PubMed
    1. Huits R, Waggoner JJ, Castilletti C. New insights into Oropouche: expanding geographic spread, mortality, vertical transmission, and birth defects. J Travel Med. 2024;29:taae117. 10.1093/jtm/taae117 - DOI - PubMed
    1. Borborema CA, Pinheiro FP, Albuquerque BC, da Rosa AP, da Rosa JF, Dourado HV. [1st occurrence of outbreaks caused by Oropouche virus in the State of Amazonas] [in Portuguese]. Rev Inst Med Trop Sao Paulo. 1982;24:132–9. - PubMed

Publication types

Supplementary concepts

LinkOut - more resources